Best, Netherlands and New Mexico, USA – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will further support oncology researchers’ efforts to analyze pathology samples by offering advanced image analysis algorithms...

Presenters: Anindita Bhoumik, M.S., Scientist, R&D, ViaCyte, Inc. Jeff Dzubay, Ph.D., Field Application Scientist, Definiens Douglas Bowman, Associate Scientific Fellow, Takeda Pharmaceuticals International Co. Broadcast...

 Continues Leadership in Simplifying Tissue Image Analysis and Improving Workflow Efficiency MUNICH -- Definiens, the global leader in Tissue Phenomics® for oncology diagnostics announced the newest version of its leading image...

CE mark includes diagnosis for routine pathology Best, The Netherlands—Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has acquired the CE mark for diagnostic use of its Philips Digital Pathology Solution. European...

In the fourth installment of my series entitled “Where do pathologists fit into Accountable Care Organizations (ACOs)?, I mentioned that I personally had not come across much information on oncology and ACOs.  In this post, I highlight...

The following post was submitted by Dr. Ben Calhoun, a practicing pathologist in Charlotte, NC. This is Ben's fourth submission in a continuing series on trying to answer the question "Where do Pathologists fit into Accountable Care...